It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

cancer

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs

World / Science & Health May 16, 2019

Scientists launch push to beat cancer's ability to adapt against treatments

Cancer scientists in Britain are launching what they call the world's first "Darwinian" drug development program in a bid to get ahead of cancer's ability to become resistant to even the newest treatments and recur in many patients. While not abandoning the search for an ...

Health insurance in Japan to cover new cancer therapy that costs ¥33 million

National / Science & Health May 15, 2019

Health insurance in Japan to cover new cancer therapy that costs ¥33 million

The anti-cancer drug Kymriah will be produced by a Tokyo-based unit of Novartis AG and is expected to carry the highest price tag of any single drug in Japan.

High levels of sunscreen ingredients end up in bloodstream, FDA researchers say

World / Science & Health May 7, 2019

High levels of sunscreen ingredients end up in bloodstream, FDA researchers say

The active ingredients of commonly used sunscreens end up in the bloodstream at much higher levels than current U.S. guidelines from health regulators and warrant further safety studies, according to a small study conducted by U.S. Food and Drug Administration researchers and published on ...

Nobel laureate Tasuku Honjo says Osaka pharmaceutical firm short-changed him for cancer drug

National / Science & Health Apr 11, 2019

Nobel laureate Tasuku Honjo says Osaka pharmaceutical firm short-changed him for cancer drug

Honjo said he wished to donate money derived from patent sales to a foundation supporting young researchers set up by Kyoto University.

Japan's 10-year cancer survival rate rises slightly to 56.3%, survey shows

National / Science & Health Apr 9, 2019

Japan's 10-year cancer survival rate rises slightly to 56.3%, survey shows

The 10-year survival rate for patients who were diagnosed with cancer between 2002 and 2005 was 56.3 percent, a survey by the National Cancer Center Japan showed Tuesday, up 0.8 percentage point from the previous survey. The five-year survival rate, covering those who received the ...

Immunotherapy: The key to a brighter future for cancer patients in Japan's aging society?

National / Science & Health Apr 3, 2019

Immunotherapy: The key to a brighter future for cancer patients in Japan's aging society?

by Takaki Tominaga

As the risk of cancer increases among the country's aging population, immunologist Tasuku Honjo is pinning his hopes on cancer treatments that shift the approach from traditional methods directly targeting cancer cells to ones that stimulate the body's immune system to fight the disease. Nobel ...

AstraZeneca bets $6.9 billion that Daiichi Sankyo therapy will transform cancer treatment

Business / Corporate Mar 29, 2019

AstraZeneca bets $6.9 billion that Daiichi Sankyo therapy will transform cancer treatment

Britain’s AstraZeneca’s biggest deal in recent memory give it access to the Japanese drugmaker’s promising but difficult to pronounce cancer treatment: trastuzumab deruxtecan.

World / Science & Health Mar 28, 2019

U.S. jury says Bayer must pay $80 million to man in Roundup cancer trial

A U.S. jury on Wednesday awarded $80 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits. The jury in San Francisco federal court ...

Marrow donor volunteers in Japan hit monthly high after swimmer Rikako Ikee's leukemia announcement

National / Science & Health Mar 26, 2019

Marrow donor volunteers in Japan hit monthly high after swimmer Rikako Ikee's leukemia announcement

The number of individuals registering as bone marrow donors reached a monthly record of 11,662 in February after teenage swimming star Rikako Ikee announced she has leukemia, according to the Japan Marrow Donor Program. New registrations exceeded 10,000 in a single month for the first ...

Aichi 5-year-old has waist-length hair shorn to help make wigs for sick kids

National / Social Issues | Regional voices: Chubu Mar 18, 2019

Aichi 5-year-old has waist-length hair shorn to help make wigs for sick kids

A 5-year-old girl from Aichi Prefecture decided to have her waist-length hair cut in January so it can be made into wigs for children who have suffered hair loss from cancer or other illnesses. Momoko Kanda was prompted to donate her hair, which had never ...

Japan Tobacco's Canada unit gets court protection after potentially crushing legal defeat in Quebec

Business / Corporate Mar 11, 2019

Japan Tobacco's Canada unit gets court protection after potentially crushing legal defeat in Quebec

Japan Tobacco Inc.'s Canadian unit was granted creditor protection by the Ontario Superior Court after a legal defeat over the risks of smoking threatens the existence of tobacco companies in the country. The court extended protection in favor of JTI-Macdonald Corp. after the company argued ...

Hanshin's Fumihito Haraguchi back in action after cancer surgery

Baseball / Japanese Baseball Mar 7, 2019

Hanshin's Fumihito Haraguchi back in action after cancer surgery

Hanshin Tigers backup catcher Fumihito Haraguchi resumed training at the club's minor league facility in Nishinomiya, Hyogo Prefecture on Thursday, after undergoing surgery for colorectal cancer. The 27-year-old, who had been diagnosed with cancer in an yearend health check last year, said Jan. 31 on ...

« 1 … 7 8 9 … 25 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times